artesunic acid has been researched along with Lung Neoplasms in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 12 (54.55) | 24.3611 |
| 2020's | 8 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, C; Li, Y; Lu, H; Tang, J; Tang, Y; Wang, Y; Xiao, X; Yang, J; Zhang, Y; Zhong, Z | 1 |
| Hu, P; Ni, C; Teng, P | 1 |
| Huang, J; Ning, N; Zhang, W | 1 |
| Cao, D; Chen, D; Chen, LW; Li, H; Li, YW; Tan, B; Wang, WY; Xia, JN; Zhang, C; Zhu, GY | 1 |
| Chen, J; Fan, Y; He, T; Li, W; Liu, Y; Wang, Q; Wang, Y; Wang, Z | 1 |
| Deng, Y; Li, W; Ma, G; Wang, Z; Wu, Q; Zhou, Q | 1 |
| Liu, J; Liu, L; Zhao, Y | 1 |
| Chen, Y; Han, H; Hu, X; Li, Q; Liu, Y; Xiong, B | 1 |
| Chen, H; Dai, H; Gu, S; Li, X; Sun, D; Zhang, Z | 1 |
| Rassias, DJ; Weathers, PJ | 1 |
| Chen, F; Chen, X; Han, K; Huang, W; Wu, C | 1 |
| Ren, T; Wang, F; Wang, X; Yang, Y; Yu, B; Zhang, X; Zhao, X | 1 |
| Hu, M; Li, F; Liu, W; Liu, Y; Liu, Z; Lu, L; Ou, R; Tong, Y; Wu, J; Zhang, G; Zheng, H; Zheng, L | 1 |
| Huang, J; Li, X; Lin, M; Luan, Z; Qian, H; Sha, M; Ye, L; Yuan, D; Zhang, L | 1 |
| Allgayer, H; Asangani, IA; Efferth, T; Rasheed, SA | 1 |
| Efferth, T; Eichhorn, T; Johnson, SW; Plinkert, PK; Sertel, S; Simon, CH | 1 |
| Dalgleish, AG; Gravett, AM; Liu, WM | 1 |
| Cen, Y; Dong, J; Jiang, W; Li, B; Li, J; Pan, X; Pang, X; Yao, Q; Zhao, Y; Zheng, J; Zhou, H | 1 |
| Chen, ZT; Lin, S; Ma, H; Sun, JG; Wang, XX; Wu, L; Yao, Q; Zhang, AM | 1 |
| Chen, TS; Pan, W; Wang, XP; Zhou, C | 1 |
| Baur, A; Berger, TG; Dieckmann, D; Efferth, T; Funk, JO; Schuler, G; Schultz, ES | 1 |
| Huang, XY; Li, DQ; Miao, LY; Xia, XH; Yu, SQ; Zhang, XP; Zhang, ZY; Zhu, YP | 1 |
1 trial(s) available for artesunic acid and Lung Neoplasms
| Article | Year |
|---|---|
[Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vinorelbine | 2008 |
21 other study(ies) available for artesunic acid and Lung Neoplasms
| Article | Year |
|---|---|
Dihydroartemisinin and artesunate inhibit aerobic glycolysis via suppressing c-Myc signaling in non-small cell lung cancer.
Topics: Animals; Artemisinins; Artesunate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Glucose; Glycolysis; Lung Neoplasms; Mice; Proto-Oncogene Proteins c-myc; Signal Transduction | 2022 |
Effects of artesunate on the malignant biological behaviors of non-small cell lung cancer in human and its mechanism.
Topics: A549 Cells; Apoptosis; Artesunate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dimethyl Sulfoxide; Humans; Lung Neoplasms; Matrix Metalloproteinase 9; Signal Transduction | 2022 |
Artesunate Suppresses the Growth of Lung Cancer Cells by Downregulating the AKT/Survivin Signaling Pathway.
Topics: A549 Cells; Animals; Apoptosis; Artesunate; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; Signal Transduction; Survivin | 2022 |
Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation.
Topics: Animals; Artesunate; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Mice; Molecular Docking Simulation; Mutation; Proteasome Endopeptidase Complex; Protein Kinase Inhibitors; Transcription Factors | 2022 |
The combination of artesunate and carboplatin exerts a synergistic anti-tumour effect on non-small cell lung cancer.
Topics: A549 Cells; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Artesunate; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Gemcitabine; Humans; Lung Neoplasms; Mitochondria; Signal Transduction | 2020 |
Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Artesunate; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Female; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Mice, Nude; Protein Kinase Inhibitors; Signal Transduction | 2021 |
Artesunate inhibits lung cancer cells via regulation of mitochondrial membrane potential and induction of apoptosis.
Topics: A549 Cells; Antineoplastic Agents; Artesunate; bcl-2-Associated X Protein; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2 | 2020 |
Artesunate-loaded porous PLGA microsphere as a pulmonary delivery system for the treatment of non-small cell lung cancer.
Topics: Artesunate; Carcinoma, Non-Small-Cell Lung; Humans; Lactic Acid; Lung Neoplasms; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity | 2021 |
The selectivity of artemisinin-based drugs on human lung normal and cancer cells.
Topics: A549 Cells; Artemisinins; Artesunate; Bronchi; Cell Line; Cell Survival; Comet Assay; DNA Damage; Epithelial Cells; Humans; Lung Neoplasms; Reactive Oxygen Species | 2018 |
Dried leaf Artemisia annua efficacy against non-small cell lung cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Artemisia annua; Artemisinins; Artesunate; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Breaks, Double-Stranded; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Plant Leaves; Signal Transduction; Xenograft Model Antitumor Assays | 2019 |
[Effects of artesunate on the invasion of lung adenocarcinoma A549 cells and expression of ICAM-1 and MMP-9].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Artemisinins; Artesunate; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Humans; Intercellular Adhesion Molecule-1; Lung Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Nude | 2013 |
Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Artemisinins; Artesunate; Carcinoma, Hepatocellular; Cell Proliferation; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Carriers; Drug Stability; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; Lung Neoplasms; Molecular Docking Simulation; Molecular Structure; Nanotechnology; Protein Conformation; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Technology, Pharmaceutical; Transferrin | 2014 |
Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
Topics: A549 Cells; Animals; Antimalarials; Artemisinins; Artesunate; beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Female; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; RNA Interference; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2016 |
Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression.
Topics: Animals; Antineoplastic Agents; Artemisinins; Artesunate; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Immunoprecipitation; Lung Neoplasms; Mice; Mice, Nude; Protein Binding; RNA Interference; RNA, Long Noncoding; RNA, Small Interfering; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2016 |
First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chick Embryo; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Humans; Lung Neoplasms; Matrix Metalloproteinases; Neoplasm Invasiveness; Neoplasm Metastasis; Polymerase Chain Reaction; RNA, Messenger; Urokinase-Type Plasminogen Activator | 2010 |
Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines.
Topics: Artemisinins; Artesunate; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Inhibitory Concentration 50; Lung Neoplasms; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Pharmacogenetics; Proto-Oncogene Proteins c-myc | 2010 |
The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies.
Topics: Antimalarials; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; Blotting, Western; Breast Neoplasms; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; Female; Flow Cytometry; Gemcitabine; Humans; Lenalidomide; Lung Neoplasms; Organoplatinum Compounds; Oxaliplatin; Thalidomide; Tumor Cells, Cultured | 2011 |
Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Artemisinins; Artesunate; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Combined Modality Therapy; Cyclin B1; Down-Regulation; Humans; Lung Neoplasms; Nitric Oxide; Radiation-Sensitizing Agents | 2011 |
The effects of artesunate on the expression of EGFR and ABCG2 in A549 human lung cancer cells and a xenograft model.
Topics: Animals; Artemisinins; Artesunate; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Phosphorylation; Proto-Oncogene Proteins c-akt; RNA, Messenger; Xenograft Model Antitumor Assays | 2011 |
Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Artemisinins; Artesunate; bcl-2 Homologous Antagonist-Killer Protein; Bcl-2-Like Protein 11; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Membrane Proteins; Proto-Oncogene Proteins; Reactive Oxygen Species; Voltage-Dependent Anion Channel 2 | 2012 |
Artesunate in the treatment of metastatic uveal melanoma--first experiences.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Artemisia; Artemisinins; Artesunate; Dacarbazine; Fatal Outcome; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Sesquiterpenes; Time Factors; Treatment Outcome; Uveal Neoplasms | 2005 |